Exelixis: A Notable Quarter

Live Chat on The Biotech Forum has been dominated by discussion of lucrative buy-write or covered call opportunities on selected biotech stocks over the past several quarters. To see what I am targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE .Mid-cap oncology concern Exelixis, Inc. (NASDAQ: EXEL ) posted more than solid first-quarter results after the bell on Tuesday. Management also raised forward guidance significantly. The company is going through somewh ...